RESOURCES | PRESENTATIONS, PUBLICATIONS, AND POSTERS | The importance of intact tumor immune microenvironment in unpropagated 3D fresh patient tumoroids for immuno-oncology drug testing
     

    The importance of intact tumor immune microenvironment in unpropagated 3D fresh patient tumoroids for immuno-oncology drug testing

    Mar 31, 2019

    Melanie Mediavilla-Varela Ph.D., Vijayendra Agrawal Ph.D., Melba Marie Page Ph.D., Jenny Kreahling, Ph.D. and Soner Altiok, M.D., Ph.D.

    DOWNLOAD poster

    OTHER PUBLICATIONS

    Employing ex vivo 3D-Screen technology for the development of rational combinations of immuno-oncology drugs in tumor organoids of fresh patient tissue

    Employing ex vivo 3D-Screen technology for the development of rational combinations of immuno-oncology drugs in tumor organoids of fresh patient tissue

    Jared Ehrhart, Ph.D., Mibel Pabón, Ph.D., Tina Pastoor...

    Jun 22, 2020

    Optimization of checkpoint inhibitor-TKI combinations in renal cell carcinoma using an ex vivo 3D tumor organoid model of fresh patient tissue with intact TME

    Optimization of checkpoint inhibitor-TKI combinations in renal cell carcinoma using an ex vivo 3D tumor organoid model of fresh patient tissue with intact TME

    Jared C. Ehrhart, Ph.D., Mibel Pabón, Ph.D., Tina Past...

    Jun 22, 2020

    Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples

    Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples

    Vijayendra Agrawal Ph.D. , Mibel Pabon, Ph.D. , Tina Pa...

    Nov 13, 2019

    SHOW MORE